title: Opana(®) ER induced thrombotic thrombocytopenic purpura.
abstract: We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana, which is a growing concern.
authors.affiliation: Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY, USA.
authors.forename: Nabil
authors.initials: N
authors.lastname: Kotbi
authors.affiliation: Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY, USA.
authors.forename: Bernadine
authors.initials: B
authors.lastname: Han
authors.affiliation: Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY, USA.
authors.forename: Duncan
authors.initials: D
authors.lastname: Cheng
authors.affiliation: Department of Psychiatry, Weill Cornell Medical College, New York-Presbyterian Hospital, White Plains, NY, USA.
authors.forename: Anna E
authors.initials: AE
authors.lastname: Odom
keywords: Opana; TTP; opioid abuse; opioid dependence